博拓生物 (688767)

Hangzhou Biotest Biotech Co., Ltd.

KSH

Tags

Brain-Computer InterfacePharmaceutical ManufacturingPharmaceuticals and HealthcareHelicobacter PyloriOverseas BusinessBiological ProductsHepatitis ConceptMargin Trading and Securities Lending

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 14933.33
  • Circulating A-Shares(W): 14933.33
  • Earnings Per Share(RMB): 0.1400
  • Net Assets Per Share(RMB): 15.6599
  • Operating Revenue(W RMB): 30807.11
  • Total Profit(W RMB): 2273.20
  • **Net Profit Attributable to Parent(W RMB) **: 2226.32
  • Net Profit Growth Rate(%): -75.04
  • Weighted Return on Equity(%): 0.9400
  • Operating Cash Flow Per Share(RMB): 0.4960
  • Undistributed Profit Per Share(RMB): 9.4104
  • Capital Reserve Per Share(RMB): 5.0664

2. Main Business

The main business covers:

  • Research, development, production, and sales of POCT diagnostic reagents

3. Company Basic Information

  • Company Name: Hangzhou Biotest Biotech Co., Ltd.
  • Listing Date: 2021-09-08
  • Industry: Pharmaceutical Manufacturing
  • Address: No. 17 Futai Road, Zhongtai Street, Yuhang District, Hangzhou City, Zhejiang Province
  • Website: https://www.biotests.com.cn/
  • Company Profile: The company was established through the overall change of the limited company and focuses on the research, development, production, and sales of POCT diagnostic reagents.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Hangzhou Tuokang Investment Co., Ltd. General Legal Person 3485.44 23.34
2 Hangzhou Kangyu Enterprise Management Consulting Partnership (Limited Partnership) General Legal Person 1680.00 11.25
3 Hangzhou Biotest Biotech Co., Ltd. - 2024 Employee Stock Ownership Plan Asset Management Plan 301.00 2.02
4 China Europe Enjoy Life Mixed Securities Investment Fund Class A Fund 217.87 1.46
5 Fuguo Positive Growth One-Year Regular Open Mixed Securities Investment Fund Fund 61.38 0.41
6 China Europe Industry Prosperity One-Year Holding Period Mixed Securities Investment Fund Class A Fund 28.78 0.19
7 China Europe Industry Xuanxuan Mixed Securities Investment Fund Class A Fund 4.24 0.03

5. Concept Sectors

  • Brain-Computer Interface
  • Helicobacter Pylori
  • Hepatitis Concept
  • Margin Trading & Securities Lending
  • Overseas Business

Remarks

  • Data update date: 2025-11-05
  • Data source: Public Market Information